Ashwini X. Maratha

Eccles Street
Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.

Journal: Therapeutic advances in medical oncology

Published: August 14, 2018

Author Correction: Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications.

Author Correction: Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications.

Journal: Scientific reports

Published: April 07, 2018

Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications.

Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications.

Journal: Scientific reports

Published: March 30, 2017

A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate.

A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib Malate.

Journal: PloS one

Published: April 11, 2016

Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Journal: JIMD reports

Published: December 06, 2015

Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.

Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.

Journal: European journal of human genetics : EJHG

Published: August 11, 2015

IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia.

IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia.

Journal: JIMD reports

Published: June 22, 2015

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

Journal: The FEBS journal

Published: May 08, 2015

Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms.

Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms.

Journal: Annals of the rheumatic diseases

Published: March 25, 2015

TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.

TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: February 01, 2013

14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.

14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.

Journal: The Journal of biological chemistry

Published: September 18, 2012

Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.

Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1.

Journal: The Journal of biological chemistry

Published: November 09, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026